Home | Business News | CBJ Newsmakers | Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing CBJ Newsmakers RecommendedNexus REIT Waives Purchase Conditions to Acquire $44.8MM of Industrial PropertiesCN Proposal Deemed Superior by Kansas City SouthernUnigold Updates Mineral Resource Estimate for the Candelones Project
